Global (R)-1-(1-Naphthalenyl)ethylamine Market Growth 2024-2030

Global (R)-1-(1-Naphthalenyl)ethylamine Market Growth 2024-2030

(R)-1-(1-Naphthalenyl)ethylamine is a light yellow to brown transparent liquid, stable at room temperature and pressure, and air-sensitive; insoluble in acids, oxidants, acid anhydrides, chloroformates, and acid chlorides. Intermediate of the drug cinacalcet for the treatment of secondary hyperparathyroidism in patients with chronic kidney disease (CKD) on dialysis and also for the treatment of hypercalcemia in patients with parathyroid cancer.

The global (R)-1-(1-Naphthalenyl)ethylamine market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.

LP Information, Inc. (LPI) ' newest research report, the “(R)-1-(1-Naphthalenyl)ethylamine Industry Forecast” looks at past sales and reviews total world (R)-1-(1-Naphthalenyl)ethylamine sales in 2023, providing a comprehensive analysis by region and market sector of projected (R)-1-(1-Naphthalenyl)ethylamine sales for 2024 through 2030. With (R)-1-(1-Naphthalenyl)ethylamine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world (R)-1-(1-Naphthalenyl)ethylamine industry.

This Insight Report provides a comprehensive analysis of the global (R)-1-(1-Naphthalenyl)ethylamine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on (R)-1-(1-Naphthalenyl)ethylamine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global (R)-1-(1-Naphthalenyl)ethylamine market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for (R)-1-(1-Naphthalenyl)ethylamine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global (R)-1-(1-Naphthalenyl)ethylamine.

United States market for (R)-1-(1-Naphthalenyl)ethylamine is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for (R)-1-(1-Naphthalenyl)ethylamine is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for (R)-1-(1-Naphthalenyl)ethylamine is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key (R)-1-(1-Naphthalenyl)ethylamine players cover BASF, Arran Chemical Company, SINOPRO.CO.LTD, Affinitis Pharma LLC, Minakem Leuna GmbH, etc. In terms of revenue, the global two largest companies occupied for a share nearly

% in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of (R)-1-(1-Naphthalenyl)ethylamine market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Purity 99%
Purity 98%

Segmentation by Application:
Pharmaceutical Intermediates
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
BASF
Arran Chemical Company
SINOPRO.CO.LTD
Affinitis Pharma LLC
Minakem Leuna GmbH
Cambrex Pharma & Biopharmaceuticals
Reuter Chemische Apparatebau KG
Yamakawa Chemical Industry Co.,Ltd.
BTC Pharm India
R L Chemical Industries Pvt Ltd
Aastrid Life Sciences Private Limited
Frolic Pharmachem
Horizon
Malladi Drugs AND Pharmaceuticals Limited
Sam Fine O Chem Limited
Anlon Healthcare Pvt Ltd
Vijaya Pharma And Life Science
MINAKEM SAS
Finorga S. A.
Changzhou Sunlight Pharmaceutical Co., Ltd. Changzhou Sunlight Pharmaceutical Co., Ltd.
Shanxi Yongjin Group
Enantiotech
Viwit
HaoYuan ChemExpress

Key Questions Addressed in this Report

What is the 10-year outlook for the global (R)-1-(1-Naphthalenyl)ethylamine market?

What factors are driving (R)-1-(1-Naphthalenyl)ethylamine market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do (R)-1-(1-Naphthalenyl)ethylamine market opportunities vary by end market size?

How does (R)-1-(1-Naphthalenyl)ethylamine break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.